References
- Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):1–6.
- Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):e363–e371.
- Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867.
- Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786.
- Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011–2016. JAMA. 2020;323(24):2526–2528.
- Mu F, Rich-Edwards J, Rimm EB, et al. Association between endometriosis and hypercholesterolemia or hypertension. Hypertension. 2017;70(1):59–65.
- Farland LV, Degnan WJ, Harris HR, et al. A prospective study of endometriosis and risk of type 2 diabetes. Diabetologia. 2021;64(3):552–560.
- Mu F, Harris HR, Rich-Edwards JW, et al. A prospective study of inflammatory markers and risk of endometriosis. Am J Epidemiol. 2018;187(3):515–522.
- Melo AS, Rosa-e-Silva JC, Rosa-e-Silva AC, et al. Unfavorable lipid profile in women with endometriosis. Fertil Steril. 2010;93(7):2433–2436.
- Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660–667.
- National Health and Nutrition Examination Survey. [cited 2023 Jun 28]. Available from: https://www.cdc.gov/nchs/nhanes/index.htm.
- National Health and Nutrition Examination Survey. NCHS Ethics Review Board (ERB) Approval. [cited 2023 Jun 28]. Available from: https://www.cdc.gov/nchs/nhanes/irba98.htm.
- Hu PW, Yang BR, Zhang XL, et al. The association between dietary inflammatory index with endometriosis: NHANES 2001–2006. PLoS One. 2023;18(4):e0283216.
- Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report. 2009;5(13):1–7.
- Shen Y, Xiao H, Hu H. Racial/ethnic differences in age at menarche and lifetime nonmedical marijuana use: results from the NHANES 2005–2016. J Racial Ethn Health Disparities. 2021;8(2):448–453.
- Cholesterol-LDL & Triglycerides (LAB13AM). [cited 2023 Jun 30]. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/LAB13AM.htm.
- Cholesterol-Total & HDL (Lab13) [cited 2023 Jun 30]. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/LAB13.htm.
- Plasma Fasting Glucose, Serum C-peptide & Insulin (LAB10AM). [cited 2023 Jun 30]. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/LAB10AM.htm.
- Dietary Interview-Total Nutrient Intakes (DRXTOT_B). [cited 2023 Jun 30]. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/2001-2002/DRXTOT_B.htm.
- Rossi HR, Nedelec R, Jarvelin MR, et al. Body size during adulthood, but not in childhood, associates with endometriosis, specifically in the peritoneal subtype-population-based life-course data from birth to late fertile age. Acta Obstet Gynecol Scand. 2021;100(7):1248–1257.
- Li S, Fu X, Wu T, et al. Role of interleukin-6 and its receptor in endometriosis. Med Sci Monit. 2017;23:3801–3807.
- Aksak T, Gümürdülü D, Çetin MT, et al. Expression of monocyte chemotactic protein 2 and tumor necrosis factor alpha in human normal endometrium and endometriotic tissues. J Gynecol Obstet Hum Reprod. 2021;50(5):101971.
- Gleason JL, Thoma ME, Zukerman Willinger N, et al. Endometriosis and uterine fibroids and their associations with elevated C-reactive protein and leukocyte telomere length among a representative sample of U.S. women: data from the national health and nutrition examination survey, 1999–2002. J Womens Health (Larchmt). 2022;31(7):1020–1028.
- Rehman K, Akash MSH, Liaqat A, et al. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr. 2017;27(3):229–236.
- Méndez-García LA, Cid-Soto M, Aguayo-Guerrero JA, et al. Low serum interleukin-6 is a differential marker of obesity-related metabolic dysfunction in women and men. J Interferon Cytokine Res. 2020;40(3):131–138.
- Badimon L, Peña E, Arderiu G, et al. C-reactive protein in atherothrombosis and angiogenesis. Front Immunol. 2018;9:430.
- Madika AL, MacDonald CJ, Gelot A, et al. Hysterectomy, non-malignant gynecological diseases, and the risk of incident hypertension: the E3N prospective cohort. Maturitas. 2021;150:22–29.
- Chiang CH, Chen W, Tsai IJ, et al. Diabetes mellitus risk after hysterectomy: a population-based retrospective cohort study. Medicine (Baltimore). 2021;100(4):e24468.
- Crook D, Howell R, Sidhu M, et al. Elevated serum lipoprotein(a) levels in young women with endometriosis. Metabolism. 1997;46(7):735–739.
- Generoso G, Janovsky C, Bittencourt MS. Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis. Curr Opin Endocrinol Diabetes Obes. 2019;26(2):109–116.
- Kilic D, Guler T, Sevgican CI, et al. Association between endometriosis and increased arterial stiffness. Kardiol Pol. 2021;79(1):58–65.